Renewal of biocidal products
Biocidal Product Renewals: What You Need to Anticipate Now
Renewing a biocidal product authorisation is becoming increasingly complex: evolving guidance, changing regulatory expectations, divergent national situations, data protection expiry, and tricky case by case scenarios.
In this webinar, we’ll break down the key renewal pathways, highlight the pitfalls to avoid, and show you how early anticipation can protect your portfolio and streamline your next RNL submission.
Biocidal Product Authorisation Renewals: Anticipating to keep Control
Renewing a biocidal product authorisation is a strategic step that raises many questions: dossier harmonisation, regulatory updates, technical changes, active substances under review, or the impact of new EU guidance. The coming years will bring significant updates (regulations, evaluation models, IUCLID requirements, etc.) and complex situations that can strongly influence renewal strategies.
This webinar aims to provide a clear overview of the main renewal scenarios, identify key risks, and explain how to anticipate effectively to avoid end of cycle complications. Without entering confidential or overly technical territory, we will highlight observed trends, potential impacts on product portfolios, and best practices for building a robust renewal (RNL) strategy.
